← back to search

Jorge L. Juncos

Emory University · US
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases, and Obsessive-Compulsive Spectrum Disorders.
h-index
45
citations
7,771
works
111
NIH funding
primary concept
email

Recent publications

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
The Lancet Neurology 2024cited by 64position: middledoi
Exploratory evaluation of baseline cognition as a predictor of perceived benefit in a study of behavioral therapy for urinary incontinence in Parkinson disease
Neurourology and Urodynamics 2022cited by 3position: middledoi
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
The Lancet Regional Health - Americas 2021cited by 42position: middledoi
Behavioral therapy for urinary symptoms in Parkinson's disease: A randomized clinical trial
Neurourology and Urodynamics 2019cited by 49position: middledoi
Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Parkinsonism & Related Disorders 2019cited by 31position: middledoi
Hypertension and progressive supranuclear palsy
Parkinsonism & Related Disorders 2019cited by 24position: middledoi
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
CNS Drugs 2018cited by 60position: middledoi
Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort
Journal of the Neurological Sciences 2017cited by 34position: middledoi
Saccades in Progressive Supranuclear Palsy–Maladapted, Irregular, Curved, and Slow
Movement Disorders Clinical Practice 2017cited by 33position: lastdoi
Environmental and occupational risk factors for progressive supranuclear palsy: Case‐control study
Movement Disorders 2016cited by 72position: middledoi
Understanding falls in progressive supranuclear palsy
Parkinsonism & Related Disorders 2016cited by 22position: middledoi
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Nature Communications 2015cited by 240position: middledoi
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
JAMA Neurology 2014cited by 389position: middledoi
Tourette syndrome deep brain stimulation: A review and updated recommendations
Movement Disorders 2014cited by 284position: middledoi
Baraitser–Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases
European Journal of Human Genetics 2014cited by 173position: middledoi
Organochlorine chemicals and neurodegeneration among elderly subjects in Costa Rica
Environmental Research 2014cited by 38position: middledoi
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease
Parkinsonism & Related Disorders 2014cited by 25position: middledoi
The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's disease
Parkinsonism & Related Disorders 2013cited by 125position: middledoi
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
Neurology 2012cited by 333position: middledoi
Reliability of a new scale for essential tremor
Movement Disorders 2012cited by 240position: middledoi
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases
Human Molecular Genetics 2012cited by 235position: middledoi
Occupational pesticide exposure and screening tests for neurodegenerative disease among an elderly population in Costa Rica
Environmental Research 2012cited by 39position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

David G. Standaert · University of Alabama at Birmingham4 papers (2016–2019)Irene Litvan · Johns Hopkins University4 papers (2016–2019)David Shprecher · University of Arizona4 papers (2016–2019)Joseph Jankovic · Phillips University4 papers (2012–2019)Connie Marras · University Health Network4 papers (2016–2019)Benzi M. Kluger · University of Rochester Medical Center4 papers (2016–2019)Deborah A. Hall · Rush University4 papers (2016–2019)Stephen G. Reich · University of Maryland, Baltimore4 papers (2016–2019)David E. Riley · Case Western Reserve University4 papers (2016–2019)Yvette Bordelon · Cedars-Sinai Medical Center3 papers (2016–2019)Catharina Wesseling · Action Network2 papers (2012–2014)Camille P. Vaughan · Emory University2 papers (2019–2022)Chadwick W. Christine · University of California, San Francisco2 papers (2014–2017)Alayne D. Markland · University of Colorado Denver2 papers (2019–2022)Kathryn L. Burgio · University of Alabama at Birmingham2 papers (2019–2022)Kyle Steenland · Emory University2 papers (2012–2014)Sotirios A. Parashos · Park Nicollet Health Services2 papers (2017–2018)Stewart A. Factor · Emory University2 papers (2014–2017)Theodore M. Johnson · Emory University2 papers (2019–2022)Carlos Singer · University of Miami2 papers (2014–2018)